Cypher Warning Letter Cites Systemic GMP Problems At Multiple Facilities

Johnson & Johnson/Cordis' inability to provide timely failure analysis reports of Cypher-related thrombosis complaints is one of several GMP violations cited in an April 1 FDA 1warning letter